Item 8.01 Other Events.

On October 19, 2021, Adagio Therapeutics, Inc. (the "Company") issued a press release entitled "Adagio Therapeutics Announces New In Vitro Data Highlighting Broad and Potent Neutralization of ADG20 Against All Known SARS-CoV-2 Variants." The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits




Exhibit
  No.                                    Description

99.1          Press release, dated October 19, 2021.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses